Choline, mood and sleep
Self-reported mood, arousal, sleep and calmness in studies of different forms.
Key points
- In healthy adults aged 18–29, self-rated mood and arousal after a single dose of choline bitartrate did not differ from placebo. This acute comparison does not support expecting a confirmed change in these feelings. [1] See the evidence 1 2
- In adults aged 40–74, lysolecithin showed no advantage over placebo in self-rated sleep or calmness over eight weeks. Based on this comparison, a confirmed improvement in sleep or calmness should not be expected when choosing this form. [2] See the evidence 1 2
Practical guide
Check the conclusions and whether they apply to your situation.
Mood and sleep were studied separately with different choline forms.
Key points
Why these conclusions
Results of two comparisons
Healthy adults aged 18–29 took a single dose of 2.5 g choline bitartrate in orange juice or placebo. Self-rated mood and arousal did not differ. [1]
Adults aged 40–74 took lysolecithin containing 480 mg lysophosphatidylcholine per day or placebo for eight weeks. No advantage was found in self-rated sleep or calmness. [2]
Self-rated mood after a single dose did not differ between groups.
| Parameter | Data |
|---|---|
| Result | Self-rated mood after a single dose did not differ between groups. Self-rated mood 6.46±1.09 versus 6.48±1.00, p=0.889. |
| Participants | Healthy adults aged 18–29; 40 began experiment 3, 37 completed it |
| Form | Choline bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally |
| Dose | Choline bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally |
| Dose basis | Choline bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally |
| Comparator | Cellulose 2.5 g in the same juice |
| Duration | Once in each phase, one week apart |
| Confidence | 1/4: Precision: small sample, exact CI for the contrast not reported.; Consistency: no comparable independent series for this outcome and comparison.; Applicability to the specified group: single dose and brief self-rating.; Possible publication bias: no data for a separate downgrade.; Study methods: df=27 for the analysis despite 37 completing the experiment; the exact analysis set is incomplete. |
| Evidence base | 1 trial |
| Sources | [1] |
Self-rated arousal after a single dose did not differ between groups.
| Parameter | Data |
|---|---|
| Result | Self-rated arousal after a single dose did not differ between groups. Self-rated arousal 4.62±1.62 versus 4.95±1.47, p=0.171. |
| Participants | Healthy adults aged 18–29; 40 began experiment 3, 37 completed it |
| Form | Choline bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally |
| Dose | Choline bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally |
| Dose basis | Choline bitartrate 2.5 g (about 1 g choline) in 400 mL orange juice, orally |
| Comparator | Cellulose 2.5 g in the same juice |
| Duration | Once in each phase, one week apart |
| Confidence | 1/4: Precision: small sample, exact CI for the contrast not reported.; Consistency: no comparable independent series for this outcome and comparison.; Applicability to the specified group: single dose and brief self-rating.; Possible publication bias: no data for a separate downgrade.; Study methods: df=27 for the analysis despite 37 completing the experiment; the exact analysis set is incomplete. |
| Evidence base | 1 trial |
| Sources | [1] |
No advantage in self-rated sleep was found over eight weeks.
| Parameter | Data |
|---|---|
| Result | No advantage in self-rated sleep was found over eight weeks. Self-rated sleep: 80.8 versus 76.5 at baseline, 80.7 versus 77.5 by week 8; no between-group advantage found. |
| Participants | 46 adults aged 40–74, 23 and 22 analyzed |
| Form | Lysolecithin orally, 480 mg lysophosphatidylcholine per day |
| Dose | Lysolecithin orally, 480 mg lysophosphatidylcholine per day |
| Dose basis | Lysolecithin orally, 480 mg lysophosphatidylcholine per day |
| Comparator | Placebo |
| Duration | 8 weeks |
| Confidence | 1/4: Precision: 45 analyzed, CI for between-group effect not extracted.; Consistency: no comparable independent series for this outcome and comparison.; Applicability to the specified group: sample without marked sleep problems; clinical anxiety not studied.; Possible publication bias: no data for a separate downgrade.; Study methods: secondary self-ratings; pronounced baseline imbalance for calmness. |
| Evidence base | 1 trial |
| Sources | [2] |
No advantage in self-rated calmness was found by the end of week eight.
| Parameter | Data |
|---|---|
| Result | No advantage in self-rated calmness was found by the end of week eight. Self-rated calmness: 73.7→82.6 versus 85.3→85.5; no final between-group advantage found. |
| Participants | 46 adults aged 40–74, 23 and 22 analyzed |
| Form | Lysolecithin orally, 480 mg lysophosphatidylcholine per day |
| Dose | Lysolecithin orally, 480 mg lysophosphatidylcholine per day |
| Dose basis | Lysolecithin orally, 480 mg lysophosphatidylcholine per day |
| Comparator | Placebo |
| Duration | 8 weeks |
| Confidence | 1/4: Precision: 45 analyzed, CI for between-group effect not extracted.; Consistency: no comparable independent series for this outcome and comparison.; Applicability to the specified group: sample without marked sleep problems; clinical anxiety not studied.; Possible publication bias: no data for a separate downgrade.; Study methods: secondary self-ratings; pronounced baseline imbalance for calmness. |
| Evidence base | 1 trial |
| Sources | [2] |
Sources
- No Acute Effects of Choline Bitartrate Food Supplements on Memory in Healthy, Young, Human Adults. https://doi.org/10.1371/journal.pone.0157714
- Effects of an 8-week intake of lysolecithin on cognitive function and concentrations of blood choline and lysophosphatidylcholine: a randomized, double-blinded, placebo-controlled trial. https://pmc.ncbi.nlm.nih.gov/articles/PMC11782770/
Methodology: Subpages evidence-led supplement pipeline v1